Monument Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Monument Capital Management's ABBV Position: Q3 2026 in Review
Monument Capital Management increased its AbbVie (ABBV) stake by 6.7% in Q3 2026, buying an estimated $111K and bringing the position to 6,936 shares worth $1.81M. The position accounts for 0.38% of the portfolio, ranked #88.
Monument Capital Management first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. The position peaked at $2.81M in Q1 2023. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Monument Capital Management held 6,936 shares of AbbVie worth $1.81M as of Q3 2026.
- Monument Capital Management bought 433 AbbVie shares in Q3 2026, an estimated $111K.
- AbbVie made up 0.38% of Monument Capital Management's portfolio in Q3 2026, its #88 holding.
- Monument Capital Management first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
- Monument Capital Management's AbbVie position peaked at $2.81M in Q1 2023.
- 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Monument Capital Management's 13F filing for Q3 2026, filed 9 Oct 2026.